Biocon Licenses Seven In Asia To DKSH

Indian Firm’s Generics To Reach Singapore And Thailand

Keen to make strides for its growing Small Molecules business, Biocon has signed an agreement with DKSH to bring seven generic formulations to markets in South East Asia.

South East Asia
Biocon's deal with DKSH will take seven generics to markets in South East Asia • Source: Shutterstock

More from Deals

More from Business